ICU Medical, Inc. (NASDAQ:ICUI) Director Robert S. Swinney sold 463 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the transaction, the director now owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of ICU Medical, Inc. (ICUI) opened at 180.05 on Friday. The firm has a market cap of $3.57 billion, a P/E ratio of 72.11 and a beta of 0.36. ICU Medical, Inc. has a 52 week low of $121.76 and a 52 week high of $182.45. The stock’s 50 day moving average is $172.54 and its 200 day moving average is $163.75.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million for the quarter, compared to the consensus estimate of $318.30 million. During the same period in the prior year, the company earned $1.15 EPS. ICU Medical’s quarterly revenue was up 242.8% on a year-over-year basis. On average, equities research analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Robert S. Swinney Sells 463 Shares of ICU Medical, Inc. (ICUI) Stock” was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/17/robert-s-swinney-sells-463-shares-of-icu-medical-inc-icui-stock.html.

Several large investors have recently made changes to their positions in ICUI. BlackRock Inc. grew its position in shares of ICU Medical by 87,088.7% during the 1st quarter. BlackRock Inc. now owns 1,769,930 shares of the medical instruments supplier’s stock valued at $270,268,000 after buying an additional 1,767,900 shares during the last quarter. Janus Henderson Group PLC bought a new stake in shares of ICU Medical during the 2nd quarter valued at about $247,072,000. Janus Capital Management LLC grew its position in shares of ICU Medical by 178.8% during the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock valued at $219,864,000 after buying an additional 923,395 shares during the last quarter. Fiera Capital Corp bought a new stake in shares of ICU Medical during the 2nd quarter valued at about $36,962,000. Finally, Vanguard Group Inc. grew its position in shares of ICU Medical by 16.3% during the 2nd quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock valued at $224,989,000 after buying an additional 183,133 shares during the last quarter. 78.13% of the stock is owned by institutional investors and hedge funds.

Several equities analysts have issued reports on the stock. Zacks Investment Research upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Monday, September 11th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. BidaskClub downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Finally, Gabelli reiterated a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $193.00.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.